The Supreme Court sided with the maker of Roundup weedkiller in a ruling expected to block thousands of lawsuits alleging it ...

A clinical trial testing two drugs against the Bundibugyo ebolavirus, which is driving a fast-moving outbreak in Central ...

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence ...

The Tarasoff case remains a pivotal marker in bioethics at the bicentennial as we now reach the country’s 250th birthday.

Women are fully capable of making difficult decisions, but meaningful choice requires trusted, vetted information,” writes ...

WASHINGTON — Democratic lawmakers have questions about the 79-year-old patient who received special access in April to ...

At BIO 2026, executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — The chair of the ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — Last year, Congress ...

Chelsea covers the Department of Health and Human Services with a particular focus on power and influence at the top. Confidential tips can be sent via Signal at chelseacirruzzo.42. WASHINGTON — ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Megan covers the intersection of ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.